Skip to main content
. 2021 Mar 16;143(11):1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686

Figure 1.

Figure 1.

Cardiovascular mortality in the general population and in patients with end-stage kidney disease. In 25- to 34-year-old patients with end-stage kidney disease, annual mortality is increased 500- to 1000-fold and corresponds to that of the ≈85-year-old general population. Adapted from Foley et al.5